Home0VY • FRA
add
NovaBridge Biosciences
Previous close
€3.34
Day range
€3.46 - €3.46
Year range
€0.56 - €5.60
Market cap
482.93M USD
Avg Volume
394.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.11M | -58.49% |
Net income | -5.50M | -121.65% |
Net profit margin | — | — |
Earnings per share | -0.07 | — |
EBITDA | -7.10M | 58.33% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 165.61M | -20.18% |
Total assets | 206.71M | -18.56% |
Total liabilities | 9.98M | -41.99% |
Total equity | 196.73M | — |
Shares outstanding | 81.79M | — |
Price to book | 1.39 | — |
Return on assets | -8.56% | — |
Return on capital | -8.84% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -5.50M | -121.65% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2014
Headquarters
Website
Employees
32
